Singapore Paincare Reports No New Developments in Subsidiary Winding-Up

Singapore Paincare Holdings Limited ( (SG:FRQ) ) has issued an announcement.

Singapore Paincare Holdings Limited has issued a monthly update on the creditors’ voluntary winding-up of its 51%-owned subsidiary, Dermatology & Laser Specialist Clinic Pte. Ltd., stating that there have been no material developments since the previous update in March. The company said it will continue to provide monthly disclosures in line with Catalist Rule 704(22) and urged shareholders to exercise caution when dealing in its securities and to seek professional advice if in doubt.

The absence of new developments suggests the winding-up process is progressing without significant change, and the continued updates aim to maintain transparency for investors during this period. The board’s guidance for shareholders to refrain from taking potentially prejudicial actions underscores the ongoing uncertainty around the subsidiary’s liquidation and its possible implications for stakeholder interests.

More about Singapore Paincare Holdings Limited

Singapore Paincare Holdings Limited operates in the healthcare sector, providing pain management and related medical services through a network of clinics and specialist practices in Singapore. The Group’s offerings span multidisciplinary treatments, and it holds majority stakes in various subsidiaries to broaden its service coverage in the local medical market.

Average Trading Volume: 54,450

Technical Sentiment Signal: Sell

Current Market Cap: S$15.09M

For an in-depth examination of FRQ stock, go to TipRanks’ Overview page.